Skip to main content

Differential Diagnosis of Vasovagal Syncope: Fibromyalgia

  • Chapter
  • First Online:
Vasovagal Syncope

Abstract

Fibromyalgia (FM) syndrome is a complex and challenging condition for healthcare systems worldwide. A chronic disease of unknown etiology, it is characterized by widespread pain and symptoms that may include fatigue, sleep disturbances, bowel and bladder disorders, mood disorders, neurocognitive impairment, presyncope, and syncope. It can develop at any age, and is similarly prevalent in different countries, cultures, and ethnic groups with a significant predominance of women. The recorded population prevalence rates range from 2 to 8 %, depending on the diagnostic criteria used. Emerging evidence indicates that increased pain processing within the central nervous system plays a primary pathophysiological role. Recent studies have identified distinct FM subgroups on the basis of their clinical, neurochemical, and neuroendocrinological abnormalities, including increased cerebrospinal fluid levels of substance P and excitatory amino acids, and functional anomalies in the hypothalamic–pituitary–adrenal (HPA) axis and the sympathoadrenal (autonomic nervous) system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Clauw DJ (2014) Fibromyalgia: a clinical review. JAMA 311:1547–1555

    Article  CAS  PubMed  Google Scholar 

  2. Vincent A, Lahr BD, Wolfe F, Clauw DJ et al (2013) Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester epidemiology project. Arthritis Care Res 65:786–792

    Article  Google Scholar 

  3. Wolfe F, Brahler E, Hinz A et al (2013) Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res 65:777–785

    Article  Google Scholar 

  4. Sarzi-Puttini P, Atzeni F, Cazzola M (2010) Neuroendocrine therapy of fibromyalgia syndrome: an update. Ann N Y Acad Sci 1193:91–97

    Article  CAS  PubMed  Google Scholar 

  5. Smythe HA, Moldofsky H (1977) Two contributions to understanding of the “fibrositis” syndrome. Bull Rheum Dis 28:92831

    Google Scholar 

  6. Yunus M, Masi AT, Calabro JJ et al (1981) Primary fibromyalgia (fibrositis): clinical study of 50 patient with matched normal controls. Semin Arthritis Rheum 11:151–171

    Article  CAS  PubMed  Google Scholar 

  7. Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172

    Article  CAS  PubMed  Google Scholar 

  8. Wolfe F, Clauw DJ, Fitzcharles M-A et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62:600–610

    Article  Google Scholar 

  9. Salaffi F, Sarzi-Puttini P (2012) Old and new criteria for the classification and diagnosis of fibromyalgia: comparison and evaluation. Clin Exp Rheumatol 30(74):3–9

    PubMed  Google Scholar 

  10. Fitzcharles MA, Boulos P (2003) Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology 42:263–267

    Article  PubMed  Google Scholar 

  11. Wolfe F, Clauw DJ, Fitzcharles MA et al (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 38:1113–1122

    Article  PubMed  Google Scholar 

  12. Rahman A, Underwood M, Carnes D (2014) Fibromyalgia. BMJ 348:1224

    Article  Google Scholar 

  13. Phillips K, Clauw DJ (2013) Central pain mechanisms in the rheumatic diseases: future directions. Arthritis Rheum 65:291–302

    Article  PubMed Central  PubMed  Google Scholar 

  14. Branco JC (2010) State-of-the-art on fibromyalgia mechanism. Acta Reumatol Port 35:10–15

    PubMed  Google Scholar 

  15. Castelli L, Tesio V, Colonna F et al (2012) Alexithymia and psychological distress in fibromyalgia: prevalence and relation with quality of life. Clin Exp Rheumatol 30(74):70–77

    PubMed  Google Scholar 

  16. Buskila D, Sarzi-Puttini P, Ablin JN (2007) The genetics of fibromyalgia syndrome. Pharmacogenomics 8:67–74

    Article  CAS  PubMed  Google Scholar 

  17. Sarzi-Puttini P, Atzeni F (2014) Fibromyalgia: a never-ending story of central and peripheral pain mechanisms. Arthritis Rheum. doi:10.1002/art.38659

    Google Scholar 

  18. Arnold LM, Fan J, Russell IJ et al (2013) The fibromyalgia family study: a genome-wide linkage scan study. Arthritis Rheum 65:1122–1128

    Article  PubMed Central  PubMed  Google Scholar 

  19. Lee YH, Choi SJ, Ji JD et al (2012) Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol Int 32:417–426

    Article  CAS  PubMed  Google Scholar 

  20. Cassisi G, Sarzi-Puttini P, Alciati A et al (2008) Symptoms and signs in fibromyalgia syndrome. Reumatismo 60(1):15–24

    PubMed  Google Scholar 

  21. Sarzi-Puttini P, Atzeni F, Mease P (2011) Chronic widespread pain or fibromyalgia? That is the question. Best Pract Res Clin Rheumatol 25:131–132

    Article  PubMed  Google Scholar 

  22. Yunus MB, Masi AT, Aldag JC (1989) Preliminary criteria for primary fibromyalgia syndrome (PFS): multivariate analysis of a consecutive series of PFS, other pain patients, and normal subjects. Clin Exp Rheumatol 7:63–69

    CAS  PubMed  Google Scholar 

  23. Jain KA, Carruthers M, Van De Sande MI et al (2004) Fibromyalgia syndrome: Canadian clinical working case definition, diagnostic and treatment protocols – a consensus document. J Musculoskel Pain 11:3–107

    Article  Google Scholar 

  24. Leavitt F, Katz RS, Golden HE et al (1986) Comparison of pain properties in fibromyalgia patients and rheumatoid arthritis patients. Arthritis Rheum 29:775–781

    Article  CAS  PubMed  Google Scholar 

  25. Staud R (2012) Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases. Curr Rheumatol Rep 14:539–548

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Abbi B, Natelson BH (2013) Is chronic fatigue syndrome the same illness as fibromyalgia: evaluating the ‘single syndrome’ hypothesis. QJM 106:3–9

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Spaeth M, Rizzi M, Sarzi-Puttini P (2011) Fibromyalgia and sleep. Best Pract Res Clin Rheumatol 25:227–239

    Article  PubMed  Google Scholar 

  28. Sergi M, Rizzi M, Braghiroli A et al (1999) Periodic breathing during sleep in patients affected by fibromyalgia syndrome. Eur Respir J 14(1):203–208

    Article  CAS  PubMed  Google Scholar 

  29. Grace GM, Nielson WR, Hopkins M et al (1999) Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol 21:477–487

    Article  CAS  PubMed  Google Scholar 

  30. Park DC, Glass JM, Minear M et al (2001) Cognitive function in fibromyalgia patients. Arthritis Rheum 44:2125–2213

    Article  CAS  PubMed  Google Scholar 

  31. Buskila D, Cohen H (2007) Comorbidity of fibromyalgia and psychiatric disorders. Curr Pain Headache Rep 11:333–338

    Article  PubMed  Google Scholar 

  32. Alciati A, Sgiarovello P, Atzeni F et al (2012) Psychiatric problems in fibromyalgia: clinical and neurobiological links between mood disorders and fibromyalgia. Reumatismo 64:268–274

    Article  CAS  PubMed  Google Scholar 

  33. Sarzi-Puttini P, Atzeni F, Diana A et al (2006) Increased neural sympathetic activation in fibromyalgia syndrome. Ann N Y Acad Sci 1069:109–117

    Article  PubMed  Google Scholar 

  34. Freeman R, Wieling W, Axelrod FB et al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69–72

    Article  PubMed  Google Scholar 

  35. Stewart JM (2003) Common syndromes of orthostatic intolerance. Pediatrics 131:968–980

    Article  Google Scholar 

  36. Staud R (2008) Autonomic dysfunction in fibromyalgia syndrome: postural orthostatic tachycardia. Curr Rheumatol Rep 10:463–466

    Article  PubMed  Google Scholar 

  37. Thieben MJ, Sandroni P, Sletten DM et al (2007) Postural orthostatic tachycardia syndrome: the Mayo Clinic experience. Mayo Clin Proc 82:308–313

    Article  CAS  PubMed  Google Scholar 

  38. Petzke F, Clauw DJ (2000) Sympathetic nervous system function in fibromyalgia. Curr Rheumatol Rep 2:116–123

    Article  CAS  PubMed  Google Scholar 

  39. Martinez-Lavin M, Hermosillo AG, Mendoza C et al (1997) Orthostatic sympathetic derangement in subjects with fibromyalgia. J Rheumatol 24:714–718

    CAS  PubMed  Google Scholar 

  40. Martínez-Lavín M, Hermosillo AG, Rosas M et al (1998) Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis. Arthritis Rheum 41(11):1966–1971

    Article  PubMed  Google Scholar 

  41. Bou-Holaigah I, Calkins H, Flynn JA et al (1997) Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exp Rheumatol 15:239–246

    CAS  PubMed  Google Scholar 

  42. Clauw DJ, Heshmat Y, Groner K et al (1996) Tilt table testing in fibromyalgia. Arthritis Rheum 39:S276

    Google Scholar 

  43. Furlan R, Colombo S, Perego F et al (2005) Abnormalities of cardiovascular neural control and reduced orthostatic intolerance in patients with primary fibromyalgia. J Rheumatol 32:1787–1793

    PubMed  Google Scholar 

  44. Lerma C, Martinez A, Ruiz N et al (2011) Nocturnal heart rate variability parameters as potential fibromyalgia biomarker: correlation with symptoms severity. Arthritis Res Ther 13(6):R185

    Article  PubMed Central  PubMed  Google Scholar 

  45. Elam M, Johansson G, Wallin B (1992) Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 48:371–375

    Article  CAS  PubMed  Google Scholar 

  46. Backman E, Bengtsson A, Bengtsson M et al (1988) Skeletal muscle function in primary fibromyalgia. Effect of regional sympathetic blockade with guanethidine. Acta Neurol Scand 77:187–191

    Article  CAS  PubMed  Google Scholar 

  47. Vallejo M, Martínez-Martínez LA, Grijalva-Quijada S et al (2013) Prevalence of fibromyalgia in vasovagal syncope. J Clin Rheumatol 19:111–114

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Piercarlo Sarzi-Puttini MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Sarzi-Puttini, P., Talotta, R., Batticciotto, A., Atzeni, F. (2015). Differential Diagnosis of Vasovagal Syncope: Fibromyalgia. In: Alboni, P., Furlan, R. (eds) Vasovagal Syncope. Springer, Cham. https://doi.org/10.1007/978-3-319-09102-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09102-0_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09101-3

  • Online ISBN: 978-3-319-09102-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics